To Evaluate SSD8432/ Ritonavir in Adults With COVID-19
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, Phase 1b clinical trial to evaluate the safety,
Pharmacodynamics, and Pharmacokinetic of SSD8432 combined with ritonavir tablets in adults
with COVID-19.